Search Results - "Hou, Mimi M."
-
1
Analyses of human vaccine-specific circulating and bone marrow-resident B cell populations reveal benefit of delayed vaccine booster dosing with blood-stage malaria antigens
Published in Frontiers in immunology (17-01-2024)“…We have previously reported primary endpoints of a clinical trial testing two vaccine platforms for the delivery of malaria DBPRII: viral vectors (ChAd63,…”
Get full text
Journal Article -
2
PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial
Published in npj vaccines (06-01-2024)“…The receptor-binding domain, region II, of the Plasmodium vivax Duffy binding protein (PvDBPII) binds the Duffy antigen on the reticulocyte surface to mediate…”
Get full text
Journal Article -
3
Higher HIV-1 evolutionary rate is associated with cytotoxic T lymphocyte escape mutations in infants
Published in Journal of virology (23-07-2024)“…Escape from cytotoxic T lymphocyte (CTL) responses toward HIV-1 Gag and Nef has been associated with reduced control of HIV-1 replication in adults. However,…”
Get more information
Journal Article -
4
Evaluation of the precision of the Plasmodium knowlesi growth inhibition assay for Plasmodium vivax Duffy-binding protein-based malaria vaccine development
Published in Vaccine (11-06-2024)“…•The PkGIA will be an essential selection tool for P. vivax vaccine development.•The error of the assay was evaluated with human anti-PvDBPII…”
Get full text
Journal Article -
5
Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection
Published in Science translational medicine (12-07-2023)“…There are no licensed vaccines against . We conducted two phase 1/2a clinical trials to assess two vaccines targeting Duffy-binding protein region II…”
Get more information
Journal Article -
6
Repeat controlled human malaria infection of healthy UK adults with blood-stage Plasmodium falciparum: Safety and parasite growth dynamics
Published in Frontiers in immunology (22-08-2022)“…In endemic settings it is known that natural malaria immunity is gradually acquired following repeated exposures. Here we sought to assess whether similar…”
Get full text
Journal Article -
7
Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial
Published in The Lancet infectious diseases (01-10-2024)“…A blood-stage Plasmodium falciparum malaria vaccine would provide a second line of defence to complement partially effective or waning immunity conferred by…”
Get full text
Journal Article -
8
Controlled human malaria infection with a clone of Plasmodium vivax with high-quality genome assembly
Published in JCI insight (08-12-2021)“…Controlled human malaria infection (CHMI) provides a highly informative means to investigate host-pathogen interactions and enable in vivo proof-of-concept…”
Get full text
Journal Article